Philips Healthcare parent Royal Philips Electronics has released a new five-year plan aimed at growth and strengthening its market position in the markets for health and well-being products.
Following up on its Vision 2010 strategy, Philips will continue to emphasize activities in key businesses such as home healthcare, LED lighting technology, and healthy living and personal care, said Philips President and CEO Gerard Kleisterlee.
Philips has also released its financial goals for the next five years, including comparable annual sales growth at least 2% higher on an annual average basis than the global gross domestic product from 2011-2015. The company is also aiming for reported annual earnings before interest, taxes, and amortization (EBITA) of between 10% and 13% of sales and earnings-per-share growth at double the rate of comparable annual sales growth over the period.
Related Reading
Philips adds nuke med to DMS pact, September 1, 2010
Philips awarded 2 telehealth contracts, August 31, 2010
Philips unveils iE33 enhancements, August 30, 2010
Philips debuts point-of-care ultrasound unit, August 26, 2010
Philips acquires Burton Medical Products, August 20, 2010
Copyright © 2010 AuntMinnie.com
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=100&q=70&w=100)
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
